HOME >> MEDICINE >> NEWS
Geodon effective in psychiatric emergencies; Sharply reduces time in restraints

STONY BROOK, NY, March 30, 2005 ---- A study conducted under real-world, Emergency Department conditions by researchers at Stony Brook University Hospital has found that the injectable form of the second generation antipsychotic Geodon (ziprasidone) effectively calms the most severely agitated patients. The results, published in the current issue of General Hospital Psychiatry, also suggest that it may be possible to reduce by as much as 40 percent the time severely agitated patients spend in restraints during psychiatric emergencies. Additionally, the researchers at Stony Brook University Hospital found that medication was as effective in treating the severe agitation associated with alcohol and drug use as it was in treating non-substance or alcohol abusing patients.

This observational study tracked the clinical outcome of 110 severely agitated patients who received Geodon IM (intramuscular formulation). Initial agitation levels were high, ranging from 6.5 to 6.9 on a scale that ranges from a high of 7.0 to a low of zero. Within 30 minutes, whether the patients were psychotic, or had abused alcohol or drugs, their agitation scores dropped to a normal range. In addition to quickly relieving agitation, the results of the new study showed a reduction in physical restraints. The time period severely agitated patients treated with Geodon IM were held in restraints dropped by 40 percent compared to the period prior to this study when similar agitated patients received conventional antipsychotics--primarily haloperidol, known by the brand name Haldol. For more than 50 years, Haldol IM has been considered the gold standard of injectable antipsychotics, but its side effect profile offers disadvantages for patients. Approved in 2002, Geodon IM is the first second generation antipsychotic approved for the rapid control of acute agitation in patients.

"Being held in physical restraint is not only unpleasant, it also can be unsafe," said Andrew Franc
'"/>


30-Mar-2005


Page: 1 2

Related medicine news :

1. Strategy effective against drug resistant tuberculosis
2. Study shows patch therapy may be as effective as oral medications
3. Chronic pain treatments more effective when taken together, new study shows
4. Costs of antidepressants could have funded effective alternatives
5. New ways to design safer & more effective topical (transdermal) drug delivery announced in the PNAS
6. Government wasting your taxpayer money on ineffective drug cure
7. Neurobehavioral function during coma, stroke rehabilitation effective for elderly
8. European folic acid policies are not effective enough
9. How effective are herbal supplements in reducing illnesses in children?
10. Cognitive behavioral therapy and medication is effective in the treatment of panic disorder
11. Study finds drug eluting stents as effective as vascular brachytherapy in preventing restenosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... of the most popular and least understood books in the Holy Scriptures, Revelation. The ... that have baffled scholars for centuries. Many have tossed it off as mere rubbish, ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Labs announces the European launch of their new low volume, high ... in Cambridge, U.K on October 4th. The ... with unprecedented speed and sensitivity while using far less sample volume ... ... ...
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical ... device is now successfully helping those with the widespread ... Fibromyalgia diagnosed Amanda in Essex, England ... and washing my hair, experiencing no sleep at all, ... painful spasm… I cannot recommend [the AVACEN 100] enough, ...
Breaking Medicine Technology:
Cached News: